Risk factors of proteinuria and potentially protective effect of renin–angiotensin system inhibitors in patients with renal cell carcinoma receiving axitinib

PURPOSE: Patients receiving vascular endothelial growth factor–tyrosine kinase inhibitors are at a risk of developing proteinuria. Renin–angiotensin system (RAS) inhibitors exert renoprotective effects and might reduce proteinuria risk in these patients. We investigated the risk factors for and prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikesue, Hiroaki, Yamaoka, Kenta, Matsumoto, Ayako, Hirabatake, Masaki, Muroi, Nobuyuki, Yamasaki, Toshinari, Kawakita, Mutsushi, Hashida, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135790/
https://www.ncbi.nlm.nih.gov/pubmed/35254504
http://dx.doi.org/10.1007/s00280-022-04408-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135790/
https://www.ncbi.nlm.nih.gov/pubmed/35254504
http://dx.doi.org/10.1007/s00280-022-04408-4

Ejemplares similares